High TNF-α levels in resting B cells negatively correlate with their response

Experimental Gerontology

Volumn 54, Issue , 2014, Pages 116-122

  Frasca, Daniela ^a   Diaz, Alain ^a,b   Romero, Maria ^a   Landin, Ana Marie ^a   Blomberg, Bonnie B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Aging; B cells; Inflammation; Vaccine responses

Indexed keywords

INFLUENZA VACCINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; B LYMPHOCYTE; CELL CULTURE; FEMALE; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA VACCINES; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84898802132     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.01.004     Document Type: Article

References (52)

1. Agrawal S., Gupta S. TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors. J. Clin. Immunol. 2011, 31:89-98.
2. Ahmed A.E., Nicholson K.G., Nguyen-Van-Tam J.S. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995, 346:591-595.
3. Biagi E., Nylund L., Candela M., Ostan R., Bucci L., Pini E., Nikkila J., Monti D., Satokari R., Franceschi C., Brigidi P., De Vos W. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010, 5:e10667.
4. Biagi E., Candela M., Franceschi C., Brigidi P. The aging gut microbiota: new perspectives. Ageing Res. Rev. 2011, 10:428-429.
5. Bryl E., Vallejo A.N., Weyand C.M., Goronzy J.J. Down-regulation of CD28 expression by TNF-alpha. J. Immunol. 2001, 167:3231-3238.
6. Deans G.D., Stiver H.G., McElhaney J.E. Influenza vaccines provide diminished protection but are cost-saving in older adults. J. Intern. Med. 2010, 267:220-227.
7. Duddy M., Niino M., Adatia F., Hebert S., Freedman M., Atkins H., Kim H.J., Bar-Or A. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 2007, 178:6092-6099.
8. Ferrucci L., Guralnik J.M., Pahor M., Corti M.C., Havlik R.J. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997, 277:728-734.
9. Festa A., D'Agostino R., Tracy R.P., Haffner S.M. Insulin Resistance Atherosclerosis, S. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002, 51:1131-1137.
10. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., Iskander J.K., Wortley P.M., Shay D.K., Bresee J.S., Cox N.J. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm. Rep. 2010, 59:1-62.
11. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured?. Nutr. Rev. 2007, 65:S173-S176.
12. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
13. Franceschi C., Valensin S., Bonafe M., Paolisso G., Yashin A.I., Monti D., De Benedictis G. The network and the remodeling theories of aging: historical background and new perspectives. Exp. Gerontol. 2000, 35:879-896.
14. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007, 128:92-105.
15. Frasca D., Blomberg B.B. Aging affects human B cell responses. J. Clin. Immunol. 2011, 31:430-435.
16. Frasca D., Landin A.M., Lechner S.C., Ryan J.G., Schwartz R., Riley R.L., Blomberg B.B. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J. Immunol. 2008, 180:5283-5290.
17. Frasca D., Diaz A., Romero M., Landin A.M., Phillips M., Lechner S.C., Ryan J.G., Blomberg B.B. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 2010, 28:8077-8084.
18. Frasca D., Diaz A., Romero M., Landin A.M., Blomberg B.B. Age effects on B cells and humoral immunity in humans. Ageing Res. Rev. 2011, 10:330-335.
19. Frasca D., Diaz A., Romero M., Phillips M., Mendez N.V., Landin A.M., Blomberg B.B. Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int. Immunol. 2012, 24:175-182.
20. Frasca D., Romero M., Diaz A., Alter-Wolf S., Ratliff M., Landin A.M., Riley R.L., Blomberg B.B. A molecular mechanism for TNF-alpha-mediated downregulation of B cell responses. J. Immunol. 2012, 188:279-286.
21. Frasca D., Diaz A., Romero M., Mendez N.V., Landin A.M., Ryan J.G., Blomberg B.B. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine 2013, 31:3603-3610.
22. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
23. Griffin W.S. Inflammation and neurodegenerative diseases. Am. J. Clin. Nutr. 2006, 83:470S-474S.
24. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med. 1995, 123:518-527.
25. Himmerich H., Fulda S., Linseisen J., Seiler H., Wolfram G., Himmerich S., Gedrich K., Pollmacher T. TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur. Cytokine Netw. 2006, 17:196-201.
26. Isaacs J.D. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists. Expert. Opin. Biol. Ther. 2009, 9:1463-1475.
27. Ito T., Suzuki Y., Mitnaul L., Vines A., Kida H., Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997, 227:493-499.
28. Keitel W.A., Cate T.R., Couch R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am. J. Epidemiol. 1988, 127:353-364.
29. Khurana S., Frasca D., Blomberg B., Golding H. AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans. PLoS Pathog. 2012, 8:e1002920.
30. Kimble R.B., Matayoshi A.B., Vannice J.L., Kung V.T., Williams C., Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 1995, 136:3054-3061.
31. Lazuardi L., Jenewein B., Wolf A.M., Pfister G., Tzankov A., Grubeck-Loebenstein B. Age-related loss of naive T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology 2005, 114:37-43.
32. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
33. Libby P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 2006, 83:456S-460S.
34. Loerbroks A., Stock C., Bosch J.A., Litaker D.G., Apfelbacher C.J. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur. J. Pub. Health 2011, 22:562-568.
35. McElhaney J.E. Influenza vaccine responses in older adults. Ageing Res. Rev. 2011, 10:379-388.
36. Monto A.S., Ansaldi F., Aspinall R., McElhaney J.E., Montano L.F., Nichol K.L., Puig-Barbera J., Schmitt J., Stephenson I. Influenza control in the 21st century: optimizing protection of older adults. Vaccine 2009, 27:5043-5053.
37. Murasko D.M., Bernstein E.D., Gardner E.M., Gross P., Munk G., Dran S., Abrutyn E. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp. Gerontol. 2002, 37:427-439.
38. Panda A., Qian F., Mohanty S., van Duin D., Newman F.K., Zhang L., Chen S., Towle V., Belshe R.B., Fikrig E., Allore H.G., Montgomery R.R., Shaw A.C. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J. Immunol. 2010, 184:2518-2527.
39. Parish S.T., Wu J.E., Effros R.B. Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3. J. Immunol. 2009, 182:4237-4243.
40. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A. Cytomegalovirus and human immunosenescence. Rev. Med. Virol. 2009, 19:47-56.
41. Pawelec G., Akbar A., Beverley P., Caruso C., Derhovanessian E., Fulop T., Griffiths P., Grubeck-Loebenstein B., Hamprecht K., Jahn G., Kern F., Koch S.D., Larbi A., Maier A.B., Macallan D., Moss P., Samson S., Strindhall J., Trannoy E., Wills M. Immunosenescence and Cytomegalovirus: where do we stand after a decade?. Immun. Ageing 2010, 7:13.
42. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
43. Sansoni P., Vescovini R., Fagnoni F., Biasini C., Zanni F., Zanlari L., Telera A., Lucchini G., Passeri G., Monti D., Franceschi C., Passeri M. The immune system in extreme longevity. Exp. Gerontol. 2008, 43:61-65.
44. Sarzi-Puttini P., Atzeni F., Doria A., Iaccarino L., Turiel M. Tumor necrosis factor-alpha, biologic agents and cardiovascular risk. Lupus 2005, 14:780-784.
45. Shi Y., Yamazaki T., Okubo Y., Uehara Y., Sugane K., Agematsu K. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J. Immunol. 2005, 175:3262-3267.
46. Simonsen L., Clarke M.J., Schonberger L.B., Arden N.H., Cox N.J., Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis. 1998, 178:53-60.
47. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis. 2007, 7:658-666.
48. Solana R., Pawelec G., Tarazona R. Aging and innate immunity. Immunity 2006, 24:491-494.
49. Sridharan A., Esposo M., Kaushal K., Tay J., Osann K., Agrawal S., Gupta S., Agrawal A. Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity. Age (Dordr) 2010, 33:363-376.
50. Vallejo A.N. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol. Rev. 2005, 205:158-169.
51. Vu T., Farish S., Jenkins M., Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002, 20:1831-1836.
52. Zimmerman R.K., Lauderdale D.S., Tan S.M., Wagener D.K. Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine 2010, 28:6470-6477.